Avalon GloboCare Corp. (ALBT)
NASDAQ: ALBT · Real-Time Price · USD
4.000
+0.290 (7.82%)
At close: Apr 28, 2025, 4:00 PM
4.050
+0.050 (1.25%)
After-hours: Apr 28, 2025, 6:00 PM EDT
Company Description
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States.
The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights.
The company was founded in 2016 and is headquartered in Freehold, New Jersey.
Avalon GloboCare Corp.
Country | United States |
Founded | 2014 |
Industry | Real Estate Services |
Sector | Real Estate |
Employees | 5 |
CEO | David Jin |
Contact Details
Address: 4400 Route 9 South, Suite 3100 Freehold, New Jersey 07728 United States | |
Phone | 732 780 4400 |
Website | avalon-globocare.com |
Stock Details
Ticker Symbol | ALBT |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001630212 |
CUSIP Number | 05344R302 |
ISIN Number | US05344R3021 |
Employer ID | 47-1685128 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dr. David K. Jin M.D., Ph.D. | Chief Executive Officer, President and Director |
Luisa Ingargiola | Chief Financial Officer |
Meng Li | Chief Marketing Officer and Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 24, 2025 | S-4 | Filing |
Apr 15, 2025 | 8-K | Current Report |
Apr 10, 2025 | 8-K | Current Report |
Apr 1, 2025 | 8-K | Current Report |
Mar 31, 2025 | 10-K | Annual Report |
Mar 10, 2025 | 425 | Filing |
Mar 10, 2025 | 8-K | Current Report |
Feb 27, 2025 | 8-K | Current Report |
Feb 18, 2025 | 8-K | Current Report |
Jan 10, 2025 | 8-K | Current Report |